Bacterial Enzymes as Targets for Drug Discovery

Grasp the cutting edge of antimicrobial research with Bacterial Enzymes as Targets for Drug Discovery, a meticulously researched guide by Punit Kaur and Priyanka Sharma. This essential volume speaks directly to medicinal chemists, microbiologists, pharmacologists, and drug-development teams seeking practical strategies to counter bacterial pathogens through enzyme-targeted therapeutics.

Delving beyond theory, the book connects molecular insight to real-world drug discovery: enzyme classification and mechanism, target validation, structure-based inhibitor design, high-throughput and fragment-based screening, resistance mechanisms, and lead optimization. Clear explanations of biochemical assays, kinetic analysis, and structure–activity relationships make complex concepts accessible to both early-career researchers and seasoned professionals.

Rich with case studies and contemporary examples, the authors spotlight clinically relevant enzyme targets—cell wall biosynthesis enzymes, bacterial proteases, metabolic enzymes, and resistance-associated modifiers—showing how inhibitor design can translate to effective leads. Computational approaches, crystallography, and translational considerations are integrated to help teams move from hit identification to candidate selection.

Whether you’re working in academia, biotech, or the pharmaceutical industry, this book offers a pragmatic roadmap to accelerate research and inform strategic decisions. Its global perspective makes it especially valuable for researchers across North America, Europe, and the Asia-Pacific region, including rapidly growing life-science hubs in India.

Concise, authoritative, and forward-looking, Bacterial Enzymes as Targets for Drug Discovery is a must-have reference for anyone focused on antibiotic innovation and enzyme-targeted therapeutics. Add it to your professional library today to stay ahead in the race against antimicrobial resistance.